I have obtained professional knowledge of market needs and regulatory processes over many years of experience in Medical Affairs\/Scientific Affairs roles for diagnostics and pharmaceutical companies.<\/p>\n
As a member of multinational teams and companies both in Germany and in the United States, I have acquired linguistic, social and cultural sensitivities.<\/p>\n
Because continuing education is a matter close to my heart, I keep myself always up to date.<\/p>\n\t
Professional career<\/strong><\/p>\nSince April 2015: Dittmann Medical Writing, Hamburg, previously Berlin – Freelance Medical Writer Qualifications<\/strong><\/p>\n tekom certificate “Technical Writer”<\/p>\n Doctorate degree in biology (University of Hamburg)<\/p>\n Qualified biologist (University of Giessen)<\/p>\n\t Current training<\/strong><\/p>\n2023: ICH-GCP-Training (Refresher) Memberships<\/strong><\/p>\n European Medical Writers Association EMWA<\/a><\/p>\nGerman Association for Pharmaceutical Medicine Portfolio hematology<\/a><\/p>\n Portfolio oncology<\/a><\/p>\n <\/p>\n\t\n <\/p>\n Portfolio neurology<\/a><\/p>\n <\/p>\n <\/p>\n\t\n <\/p>\n Portfolio diagnostics and laboratory medicine<\/a><\/p>\n\t from areas such as infectiology, gastroenterology and other specialist areas can be found in my portfolio<\/a>.<\/p>\n
\n2013-2014: Otsuka Pharma GmbH, Frankfurt – Medical Science Manager CNS
\n2008-2013: Sysmex Europe GmbH, Norderstedt – Medical Afffairs Manager EMEA with a focus on Scientific Marketing and Medical Writing in the field of hematology
\n2007-2008: Medical University of South Carolina, Charleston, USA – Postdoctoral Fellow
\n2007: Conergy AG, Hamburg – Technical Writer (advanced training)
\n2006: SIT Skin GmbH, Hamburg: Director of In Vitro Studies and In Vivo Photobiological Studies (dermatologic contract research)
\n2002-2005: Heinrich Pette Institute for Experimental Virology, Hamburg – Doctoral Student and Postdoctoral Fellow\n\t
\n2020: ICH-GCP-Training (Refresher)
\n2020: EMWA Virtual Expert Seminar Series “Life cycle safety and risk management for medical devices”
\n2017: ICH-GCP training (refresher)
\n2016: Update haematology\/oncology
\n2015: Preparing regulatory submissions
\n2014: Clinical data management\n\t
\nDGPharMed<\/a>\n\tExpertise<\/h2>\n
Haematology and oncology
\n<\/strong><\/h3>\nHaematooncology
\nStem cell transplantation
\nBreast carcinoma
\nProstate carcinoma
\nStandard care for oncologic diseases\nNeurology
\n<\/strong><\/h3>\nPeripheral neuropathy
\nPain
\nParkinson’s disease
\nAlzheimer’ disease\nDiagnostics and laboratory medicine<\/strong><\/h3>\nBiomarkers (endocrinological markers, cardiac markers, tumour markers)
\nFlow cytometry
\nLaboratory haematology
\nCerebrospinal fluid diagnostics\nFurther indications<\/h3>\n